Bio-Rad Laboratories (BIO) Insider Trading & Ownership $260.92 +2.95 (+1.14%) As of 03/7/2025 03:58 PM Eastern Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends Bio-Rad Laboratories (NYSE:BIO) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage17.06%Number OfInsiders Buying(Last 12 Months)0Number OfInsiders Selling(Last 12 Months)3Amount OfInsider Selling(Last 12 Months)$1.30 M Get BIO Insider Trade Alerts Want to know when executives and insiders are buying or selling Bio-Rad Laboratories stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address BIO Insider Buying and Selling by Quarter Remove Ads Bio-Rad Laboratories Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails9/6/2024Andrew J LastCOOSell3,000$329.94$989,820.00 9/4/2024James BarryEVPSell623$330.49$205,895.27 6/13/2024Michael CrowleyEVPSell369$281.91$104,024.79 (Data available from 1/1/2013 forward) BIO Insider Trading Activity - Frequently Asked Questions Who is on Bio-Rad Laboratories's Insider Roster? The list of insiders at Bio-Rad Laboratories includes Ajit Ramalingam, Andrew J Last, Dara Wright, James Barry, Michael Crowley, and Timothy S Ernst. Learn more on insiders at BIO. What percentage of Bio-Rad Laboratories stock is owned by insiders? 17.06% of Bio-Rad Laboratories stock is owned by insiders. Learn more on BIO's insider holdings. Which Bio-Rad Laboratories insiders have been selling company stock? The following insiders have sold BIO shares in the last 24 months: Ajit Ramalingam ($72,923.40), Andrew J Last ($989,820.00), Dara Wright ($358,992.00), James Barry ($205,895.27), Michael Crowley ($1,497,593.99), and Timothy S Ernst ($1,045,067.00). How much insider selling is happening at Bio-Rad Laboratories? Insiders have sold a total of 12,182 Bio-Rad Laboratories shares in the last 24 months for a total of $4,170,291.66 sold. Bio-Rad Laboratories Key ExecutivesMr. Norman D. Schwartz (Age 74)Chairman, CEO & President Compensation: $1.25MDr. Andrew J. Last Ph.D. (Age 64)Executive VP & COO Compensation: $682.29kMr. Roop K. Lakkaraju (Age 53)Executive VP & CFO Ms. Tania DeVilliers (Age 50)Senior Director, Corporate Controller & Interim Principal Accounting Officer Mr. Yong ChungVice President of Investor RelationsMatthew WernerSenior Vice President and Chief Compliance & Privacy OfficerCourtney C. EnloeExecutive VP, General Counsel & SecretaryMs. Colleen Corey (Age 62)Executive Vice President of Global Human Resources Mr. Michael Crowley (Age 62)Executive Vice President of Global Commercial Operations Compensation: $974.94kLee BoydSenior Vice President of Global Commercial Operations - Asia Pacific More Insider Trading Tools from MarketBeat Related Companies MTD Insider Transactions WAT Insider Transactions ILMN Insider Transactions TECH Insider Transactions CRL Insider Transactions BRKR Insider Transactions PACB Insider Transactions HBIO Insider Transactions TMO Insider Transactions A Insider Transactions Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles 2 Stocks Insiders Are Buying and 1 They're Selling3 Stocks With Robust Growth Outlooks Insiders Are BuyingMETA Stock: Insider Selling Ramps Up—What It Means for InvestorsThese Are the Dividend Stocks Insiders Bought in JanuaryInsider Selling in Tech Stocks Spikes in Q4 This page (NYSE:BIO) was last updated on 3/10/2025 by MarketBeat.com Staff From Our PartnersURGENT: This Altcoin Opportunity Won’t Wait – Act NowCrypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happen...Crypto Swap Profits | SponsoredA market crash is coming—here’s whenThe stock market cycle I've used to identify the most likely day of the next market crash is the exact same in...Chaikin Analytics | SponsoredSecret financial plot unfolding in Washington DC… [DEVELOPING]What stocks are next up to soar in 2025? I believe I’ve found the answer - and it might surprise you. Yo...Timothy Sykes | Sponsored“Amazon Coin” set to outperform BitcoinChris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredJust Revealed: The chip company making AI look primitiveIn his just-released video presentation, this renowned market strategist — who's been called "one of the most ...InvestorPlace | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredDOGE Social Security bombshell?Elon Musk just dropped another bombshell... He revealed his DOGE organization has been taking aim at Social...Altimetry | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Bio-Rad Laboratories, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Bio-Rad Laboratories With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
